Literature DB >> 21900518

Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection.

Melinda M Pettigrew1, Janneane F Gent, Richard B Pyles, Aaron L Miller, Johanna Nokso-Koivisto, Tasnee Chonmaitree.   

Abstract

Acute otitis media (AOM) is a common complication of upper respiratory tract infection whose pathogenesis involves both viruses and bacteria. We examined risks of acute otitis media associated with specific combinations of respiratory viruses and acute otitis media bacterial pathogens. Data were from a prospective study of children ages 6 to 36 months and included viral and bacterial culture and quantitative PCR for respiratory syncytial virus (RSV), human bocavirus, and human metapneumovirus. Repeated-measure logistic regression was used to assess the relationship between specific viruses, bacteria, and the risk of acute otitis media complicating upper respiratory tract infection. In unadjusted analyses of data from 194 children, adenovirus, bocavirus, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis were significantly associated with AOM (P < 0.05 by χ(2) test). Children with high respiratory syncytial virus loads (≥3.16 × 10(7) copies/ml) experienced increased acute otitis media risk. Higher viral loads of bocavirus and metapneumovirus were not significantly associated with acute otitis media. In adjusted models controlling for the presence of key viruses, bacteria, and acute otitis media risk factors, acute otitis media risk was independently associated with high RSV viral load with Streptococcus pneumoniae (odds ratio [OR], 4.40; 95% confidence interval [CI], 1.90 and 10.19) and Haemophilus influenzae (OR, 2.04; 95% CI, 1.38 and 3.02). The risk was higher for the presence of bocavirus and H. influenzae together (OR, 3.61; 95% CI, 1.90 and 6.86). Acute otitis media risk differs by the specific viruses and bacteria involved. Acute otitis media prevention efforts should consider methods for reducing infections caused by respiratory syncytial virus, bocavirus, and adenovirus in addition to acute otitis media bacterial pathogens.

Entities:  

Mesh:

Year:  2011        PMID: 21900518      PMCID: PMC3209086          DOI: 10.1128/JCM.01186-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  37 in total

Review 1.  Otitis media and its consequences: beyond the earache.

Authors:  Anne Vergison; Ron Dagan; Adriano Arguedas; Jan Bonhoeffer; Robert Cohen; Ingeborg Dhooge; Alejandro Hoberman; Johannes Liese; Paola Marchisio; Arto A Palmu; G Thomas Ray; Elisabeth A M Sanders; Eric A F Simões; Matti Uhari; Johan van Eldere; Stephen I Pelton
Journal:  Lancet Infect Dis       Date:  2010-03       Impact factor: 25.071

2.  Frequent and prolonged shedding of bocavirus in young children attending daycare.

Authors:  Emily T Martin; Mary P Fairchok; Jane Kuypers; Amalia Magaret; Danielle M Zerr; Anna Wald; Janet A Englund
Journal:  J Infect Dis       Date:  2010-06-01       Impact factor: 5.226

3.  Novel human bocavirus in children with acute respiratory tract infection.

Authors:  Jing-rong Song; Yu Jin; Zhi-ping Xie; Han-chun Gao; Ni-guang Xiao; Wei-xia Chen; Zi-qian Xu; Kun-long Yan; Yang Zhao; Yun-de Hou; Zhao-jun Duan
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

4.  New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine.

Authors:  Janet R Casey; Diana G Adlowitz; Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2010-04       Impact factor: 2.129

5.  Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings.

Authors:  Carlos G Grijalva; J Pekka Nuorti; Marie R Griffin
Journal:  JAMA       Date:  2009-08-19       Impact factor: 56.272

6.  A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion.

Authors:  F W Henderson; A M Collier; M A Sanyal; J M Watkins; D L Fairclough; W A Clyde; F W Denny
Journal:  N Engl J Med       Date:  1982-06-10       Impact factor: 91.245

Review 7.  Importance of respiratory viruses in acute otitis media.

Authors:  Terho Heikkinen; Tasnee Chonmaitree
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

8.  Clinical and microbiological impact of human bocavirus on children with acute otitis media.

Authors:  Levent Bekir Beder; Muneki Hotomi; Masashi Ogami; Kazuma Yamauchi; Jun Shimada; Dewan Sakhawat Billal; Nobuhisa Ishiguro; Noboru Yamanaka
Journal:  Eur J Pediatr       Date:  2009-02-17       Impact factor: 3.183

9.  A newly discovered human pneumovirus isolated from young children with respiratory tract disease.

Authors:  B G van den Hoogen; J C de Jong; J Groen; T Kuiken; R de Groot; R A Fouchier; A D Osterhaus
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

Review 10.  Immunopathogenesis of polymicrobial otitis media.

Authors:  Lauren O Bakaletz
Journal:  J Leukoc Biol       Date:  2009-10-20       Impact factor: 4.962

View more
  70 in total

Review 1.  Epigenetics and the dynamics of chromatin during adenovirus infections.

Authors:  Kelsey L Lynch; Linda R Gooding; Charlie Garnett-Benson; David A Ornelles; Daphne C Avgousti
Journal:  FEBS Lett       Date:  2019-12-15       Impact factor: 4.124

Review 2.  The host immune dynamics of pneumococcal colonization: implications for novel vaccine development.

Authors:  M Nadeem Khan; Michael E Pichichero
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  16S community profiling identifies proton pump inhibitor related differences in gastric, lung, and oropharyngeal microflora.

Authors:  Rachel Rosen; Lan Hu; Janine Amirault; Umakanth Khatwa; Doyle V Ward; Andrew Onderdonk
Journal:  J Pediatr       Date:  2015-02-04       Impact factor: 4.406

4.  Directed vaccination against pneumococcal disease.

Authors:  Yi Li; Andrew Hill; Marie Beitelshees; Shuai Shao; Jonathan F Lovell; Bruce A Davidson; Paul R Knight; Anders P Hakansson; Blaine A Pfeifer; Charles H Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-06       Impact factor: 11.205

5.  Replication of type 5 adenovirus promotes middle ear infection by Streptococcus pneumoniae in the chinchilla model of otitis media.

Authors:  Kyle A Murrah; Roberta L Turner; Bing Pang; Antonia C Perez; Jennifer L Reimche; Lauren B King; John Wren; Uma Gandhi; W Edward Swords; David A Ornelles
Journal:  Pathog Dis       Date:  2015-02-26       Impact factor: 3.166

6.  Moraxella catarrhalis Might Be More Common than Expected in Acute Otitis Media in Young Finnish Children.

Authors:  Saara Sillanpää; Sami Oikarinen; Markku Sipilä; Lenka Kramna; Markus Rautiainen; Heini Huhtala; Janne Aittoniemi; Jussi Laranne; Heikki Hyöty; Ondrej Cinek
Journal:  J Clin Microbiol       Date:  2016-07-13       Impact factor: 5.948

7.  Serum antibody response to Moraxella catarrhalis proteins in stringently defined otitis prone children.

Authors:  Dabin Ren; Anthony L Almudevar; Timothy F Murphy; Eric R Lafontaine; Anthony A Campagnari; Nicole Luke-Marshall; Michael E Pichichero
Journal:  Vaccine       Date:  2017-07-26       Impact factor: 3.641

8.  Seasonality of acute otitis media and the role of respiratory viral activity in children.

Authors:  Chris Stockmann; Krow Ampofo; Adam L Hersh; Scott T Carleton; Kent Korgenski; Xiaoming Sheng; Andrew T Pavia; Carrie L Byington
Journal:  Pediatr Infect Dis J       Date:  2013-04       Impact factor: 2.129

9.  Impact of respiratory viral infections on α-hemolytic streptococci and otopathogens in the nasopharynx of young children.

Authors:  Victoria Friedel; Arthur Chang; Jennifer Wills; Roberto Vargas; Qingfu Xu; Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2013-01       Impact factor: 2.129

Review 10.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.